Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.81 -1.05%
EPS Growth %: -25.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -25.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
- Rothschild Redburn Starts Digital Realty Trust (DLR) at Buy
- Rothschild Redburn Starts Minimax Group Inc (100:HK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
